A Trace ‘Tides Primer on understanding the copper-binding tripeptide behind the familiar name

By: Laura Mildon

GHK-Cu is a copper complex of a three-amino-acid peptide. GHK identifies the sequence glycine–histidine–lysine, while Cu is the chemical symbol for copper. The peptide has a strong affinity for copper(II), written Cu²⁺. Its research history spans cell biology, metal-binding chemistry, and studies of skin-related experimental systems.

What makes a copper peptide

GHK contains three amino acids joined by peptide bonds, making it a tripeptide. When atoms in the peptide bind a copper ion, they form a coordination complex. Copper is not an additional amino acid.

GHK names the unbound peptide; GHK-Cu names its copper complex. Copper binding changes the chemical system, so findings about one should not automatically be assigned to the other.

Experimental study of GHK copper binding and structure

Chemical identity

PubChem’s Cu-GHK record lists C₁₄H₂₄CuN₆O₄ and 403.92 g/mol. It represents peptide and copper as separate components, without drawing their coordination bonds. It is not a universal specification for every material sold as GHK-Cu.

Copper binding, protonation, counterions, and associated water affect chemical descriptions. The exact peptide and copper-containing form must be identified.

PubChem record for the unbound GHK peptide

PubChem Cu-GHK composition and structure record

History and origins

Loren Pickart and M. Michael Thaler reported a tripeptide isolated from human serum in 1973. Their early experiments concerned cultured liver cells. A same-year paper examined synthetic GHK in cell cultures.

In 1982, Freedman and colleagues described the copper complex in solution. These publications distinguish the peptide’s early identification from later characterization of its copper binding.

Original human-serum peptide publication from 1973

Synthetic peptide study from 1973

Selected published research

These studies help explain why GHK-Cu attracts scientific interest. Each answers a particular experimental question; none establishes that a commercially supplied research material has the same properties or produces a clinical benefit.

Solution structure by Freedman and colleagues in 1982

Researchers used spectroscopy—methods that examine how matter interacts with electromagnetic energy—to investigate the copper complex in solution. They found evidence that nitrogen atoms in the peptide coordinate copper, including a nitrogen atom in histidine’s ring.

They also found that the solution structure differed from a previously described solid-state structure. This is an important reminder that a crystalline material and a dissolved complex can have different arrangements.

Read the original paper in Biochemistry

Collagen synthesis in cell cultures in 1988

Maquart and colleagues studied GHK-Cu in fibroblast cultures. Fibroblasts are cells that produce components of the extracellular matrix—the surrounding network of structural proteins and other molecules.

The authors reported increased collagen synthesis under their experimental conditions. That finding concerns cultured cells. It does not establish the properties or performance of the research material offered by a supplier.

Read the original paper in FEBS Letters

Copper measurements in isolated skin tissue in 2011

Hostynek, Dreher, and Maibach examined copper retention and movement across isolated human skin preparations in laboratory diffusion cells. The paper appeared online in 2010 and in a 2011 journal issue.

Their analytical method measured copper. Detecting copper does not establish that the intact GHK-Cu complex remained unchanged throughout the experiment; the authors discussed possible separation and rebinding of copper. This was a laboratory tissue study, not evidence of a clinical benefit.

Read the original paper in Inflammation Research

What remains unresolved

The exact chemical form and experimental environment affect how GHK-Cu should be interpreted. A cell-culture finding, a copper measurement, and a structural study answer different questions. Copper detection alone does not establish the presence of an unchanged peptide–copper complex.

Published findings should be assessed against the material tested, the analytical method, and the experimental model. These studies do not establish an intended application for a commercially supplied research material.

Regulatory context

GHK-Cu research materials are not FDA-approved medicines. Chemical database records and published research do not constitute FDA approval or establish safety and effectiveness for a product.

In its published drug-compounding safety discussion, FDA identifies potential concerns involving aggregation, peptide-related impurities, and immune responses for GHK-Cu in a specific compounding context. These concerns are context-specific and should not be generalized to every material bearing the same short name.

FDA published discussion of GHK-Cu and compounding safety

Research and regulatory sources checked October 13, 2026.

DISCLAIMER: These statements are for research purposes only and have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Why choose Trace 'Tides? 

Because trust starts with real people, clear answers, and quality you can verify. We have a certified peptide specialist on staff, a phone number that connects you with a real human, and a physical location you can visit by appointment. Call or text us—we’re delighted to answer your questions and address your concerns. We also make checkout straightforward by accepting credit cards, without asking you to use cryptocurrency or connect your bank account to an unfamiliar payment app. And every peptide we sell is tested for purity and endotoxins by licensed U.S. laboratories, so you can choose your research peptides with confidence.